LEGN Stock: Price, Earnings History and SEC Filings
Legend Biotech Corporation (LEGN) last traded at $21.63, down 3.00% on the latest session and up 8.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.09 against an analyst estimate of $0.12, a miss of 25.0%.
$21.63 -3.00%
1 month+8.75%
52-week high$37.50
52-week low$16.24
Volume2.19M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LEGN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $0.09 | $0.12 | -25.00% |
| Mar 2026 | May 12, 2026 | $-0.15 | $-0.02 | -650.00% |
| Dec 2025 | Mar 10, 2026 | $-0.08 | $-0.17 | +52.94% |
| Sep 2025 | Nov 12, 2025 | $-0.11 | $-0.13 | +15.38% |
LEGN beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for LEGN
SEC filing data is not available right now. You can search for LEGN on SEC EDGAR.
LEGN news
- Legend Biotech Corporation Sponsored ADR (LEGN) Recently Broke Out Above the 200-Day Moving AverageOct 29, 2026 · finance.yahoo.com
- Legend Biotech (LEGN) Stock Could Trade Below Its Sales BackdropOct 28, 2026 · finance.yahoo.com
- Legend Biotech Corporation Sponsored ADR (LEGN) Crossed Above the 50-Day Moving Average: What That Means for InvestorsOct 27, 2026 · finance.yahoo.com
- Legend Biotech to Host Investor Conference Call on Third Quarter 2026 ResultsOct 27, 2026 · finance.yahoo.com
- Legend Biotech Corp. Sponsored ADROct 23, 2026 · cnn.com
- Legend Biotech: Carvykti Makes Billions, But The Profits Are ElusiveOct 22, 2026 · seekingalpha.com
- Morgan Stanley turns bearish on Vonovia, LEG as Berlin housing risks mountOct 20, 2026 · finance.yahoo.com
About Legend Biotech Corporation
Legend Biotech Corporation (LEGN) is a US-listed public company on Nasdaq.